Corrigendum: Analysis of inflammatory cytokines in human blood, breath condensate, and urine using a multiplex immunoassay platform (Biomarkers (2014) 20, 01 DOI: 10.3109/1354750X.2014.988646);Analysis of inflammatory cytokines in human blood, breath condensate, and urine using a multiplex immunoassay platform

Biomarkers

Volumn 20, Issue 1, 2015, Pages 35-46

  Stiegel, Matthew A ^a   Pleil, Joachim D ^b   Sobus, Jon R ^b   Morgan, Marsha K ^b   Madden, Michael C ^b  

^a University of North Carolina at Chapel Hill   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Breath analysis; Cytokines; Ecotoxicology; Environmental pollution; Growth factors; Immunotoxicity; Inflammatory mediators

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD; BODY FLUID; BREATHING; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; HUMAN; IN VIVO STUDY; INFLAMMATION; NORMAL HUMAN; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; TH1 CELL; TH2 CELL; UNITED STATES; URINALYSIS; URINE; CALIBRATION; EXHALATION; MIDDLE AGED; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; STANDARD; YOUNG ADULT;

ADULT; CALIBRATION; CYTOKINES; EXHALATION; HUMANS; MIDDLE AGED; REFERENCE STANDARDS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84921790021     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2015.1006911     Document Type: Erratum

References (48)

1. Ankley GT, Bennett RS, Erickson RJ, et al. (2010). Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730-41.
2. Bastarache JA, Koyama T, Wickersham NE, Ware LB. (2014). Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples. J Immunol Methods 408:13-23.
3. Bomert M, Kollisch G, Roponen M, et al. (2011). Analytical performance of a multiplexed, bead-based cytokine detection system in small volume samples. Clin Chem Lab Med 49:1691-3.
4. Bonisch U, Bohme A, Kohajda T, et al. (2012). Volatile organic compounds enhance allergic airway inflammation in an experimental mouse model. PLoS One 7:e39817.
5. Boonpiyathad S, Pornsuriyasak P, Buranapraditkun S, Klaewsongkram J. (2013). Interleukin-2 levels in exhaled breath condensates, asthma severity, and asthma control in nonallergic asthma. Allergy Asthma Proc 34:e35-41.
6. Campbell A. (2004). Inflammation, neurodegenerative diseases, and environmental exposures. Ann N Y Acad Sci 1035:117-32.
7. Candela JV, Park E, Gerspach JM, et al. (1998). Evaluation of urinary IL-1alpha and IL-1beta in gravid females and patients with bacterial cystitis and microscopic hematuria. Urol Res 26:175-80.
8. Cannas A, Calvo L, Chiacchio T, et al. (2010). IP-10 detection in urine is associated with lung diseases. BMC Infect Dis 10:333.
9. Chowdhury F, Williams A, Johnson P. (2009). Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. J Immunol Methods 340:55-64.
10. Chung KF, Barnes PJ. (1999). Cytokines in asthma. Thorax 54:825-57.
11. Cousins DJ, Lee TH, Staynov DZ. (2002). Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J Immunol 169:2498-506.
12. Devlin RB, Duncan KE, Jardim M, et al. (2012). Controlled exposure of healthy young volunteers to ozone causes cardiovascular effects. Circulation 126:104-11.
13. Devlin RB, Mcdonnell WF, Mann R, et al. (1991). Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol 4:72-81.
14. Duramad P, Tager IB, Holland NT. (2007). Cytokines and other immunological biomarkers in children's environmental health studies. Toxicol Lett 172:48-59.
15. Dybing E, Lovdal T, Hetland RB, et al. (2004). Respiratory allergy adjuvant and inflammatory effects of urban ambient particles. Toxicology 198:307-14.
16. Elenkov IJ, Chrousos GP. (1999). Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 10:359-68.
17. Elshal MF, Mccoy JP. (2006). Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 38:317-23.
18. Ghoniem G, Faruqui N, Elmissiry M, et al. (2011). Differential profile analysis of urinary cytokines in patients with overactive bladder. Int Urogynecol J 22:953-61.
19. Goldbergova MP, Pavek N, Lipkova J, et al. (2012). Circulating cytokine pattern and factors describing rheumatoid arthritis: IL-15 as one of the biomarkers for RA? Biomarkers 17:655-62
20. Jacobs R, Pawlak CR, Mikeska E, et al. (2001). Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure. Rheumatology (Oxford) 40:868-75.
21. Kampa M, Castanas E. (2008). Human health effects of air pollution. Environ Pollut 151:362-7.
22. Koh KB, Lee Y, Beyn KM, et al. (2008). Counter-stress effects of relaxation on proinflammatory and anti-inflammatory cytokines. Brain Behav Immun 22:1130-7.
23. Malekzadeh A, De Groot V, Beckerman H, et al. (2012). Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases. Methods 56:508-13.
24. Matsunaga K, Yanagisawa S, Ichikawa T, et al. (2006). Airway cytokine expression measured by means of protein array in exhaled breath condensate: correlation with physiologic properties in asthmatic patients. J Allergy Clin Immunol 118:84-90.
25. Meso Scale Discovery. (2012). MSD biomarker assays: human TH1/TH2 10-plex ultra-sensitive kit. Available at: www.mesoscale.com.
26. Murase T, Kitamura H, Kochi T, et al. (2013). Distributions and ranges of values of blood and urinary biomarker of inflammation and oxidative stress in the workers engaged in office machine manufactures: evaluation of reference values. Clin Chem Lab Med 51:421-8.
27. Nakamura M, Nakamura H, Minematsu N, et al. (2014). Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease. Biomarkers 19:368-77.
28. National Research Council of the National Academies. (2012). Exposure science in the 21st century: a vision and strategy. Washington (DC): The National Academies Press.
29. Ostrowski K, Hermann C, Bangash A, et al. (1998). A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol 513:889-94.
30. Pleil JD, Hubbard HF, Sobus JR, Madden MC. (2008). Volatile polar metabolites in exhaled breath condensate (EBC): collection and analysis. J Breath Res 2:026001.
31. Pleil JD. (2009). Influence of systems biology response and environmental exposure level on between-subject variability in breath and blood biomarkers. Biomarkers 14:560-71.
32. Pleil JD. (2012). Categorizing biomarkers of the human exposome and developing metrics for assessing environmental sustainability. J Toxicol Environ Health B Crit Rev 15:264-80.
33. Pleil JD, Sheldon LS. (2011). Adapting concepts from systems biology to develop systems exposure event networks for exposure science research. Biomarkers 16:99-105.
34. Pleil JD, Sobus JR. (2013). Estimating lifetime risk from spot biomarker data and intraclass correlation coefficients (ICC). J Toxicol Environ Health A 76:747-66.
35. Pleil JD, Sobus JR, Stiege MA, et al. (2014). Estimating common parameters of log-normally distributed environmental and biomonitoring data: harmonizing disparate statistics from publications. J Toxicol Environ Health B Crit Rev 17:341-368.
36. Pleil JD, Stiegel MA. (2013). Evolution of environmental exposure science: using breath-borne biomarkers for "discovery" of the human exposome. Anal Chem 85:9984-90.
37. Pleil JD, Williams MA, Sobus JR. (2012). Chemical safety for sustainability (CSS): human in vivo biomonitoring data for complementing results from in vitro toxicology - a commentary. Toxicol Lett 215:201-7.
38. Pope III CA, Burnett RT, Thurston GD, et al. (2004). Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 109:71-7.
39. Rappaport SM, Kupper LL. (2008). Quantitative exposure assessment. El Cerrito: Cali. S.M. Rappaport.
40. Richards FJ. (1959). A flexible growth function for empirical use. J Exp Bot 10:290-300.
41. Robroeks CM, Jobsis Q, Damoiseaux JG, et al. (2006). Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis. Ann Allergy Asthma Immunol 96:349-55.
42. Sack U, Scheibe R, Wotzel M, et al. (2006). Multiplex analysis of cytokines in exhaled breath condensate. Cytometry A 69:169-72.
43. Salvi S, Blomberg A, Rudell B, et al. (1999). Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med 159:702-9.
44. Sanchez Perez MJ, Gonzalez-Reimers E, Santolaria-Fernandez F, et al. (2006). Lipid peroxidation and serum cytokines in acute alcoholic hepatitis. Alcohol Alcohol 41:593-7.
45. Selgrade M, Boykin EH, Haykal-Coates N, et al. (2006). Inconsistencies between cytokine profiles, antibody responses, and respiratory hyperresponsiveness following dermal exposure to isocyanates. Toxicol Sci 94:108-17.
46. Tighe P, Negm O, Todd I, Fairclough L. (2013). Utility, reliability and reproducibility of immunoassay multiplex kits. Methods 61:23-9.
47. Van Bussel BC, Ferreira I, Van De Waarenburg MP, et al. (2013). Multiple inflammatory biomarker detection in a prospective cohort study: a cross-validation between well-established single-biomarker techniques and an electrochemiluminescense-based multi-array platform. PLoS One 8:e58576.
48. Vinken M. (2013). The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology 312:158-65.